P2Y 12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions

It remains unclear whether P2Y inhibitor monotherapy preserves ischemic protection while limiting bleeding risk compared with dual antiplatelet therapy (DAPT) after complex percutaneous coronary intervention (PCI). We sought to assess the effects of P2Y inhibitor monotherapy after 1-month to 3-month...

Full description

Bibliographic Details

Published in:	Journal of the American College of Cardiology Vol. 81; no. 6; p. 537
Main Authors:	Gragnano, Felice, Mehran, Roxana, Branca, Mattia, Franzone, Anna, Baber, Usman, Jang, Yangsoo, Kimura, Takeshi, Hahn, Joo-Yong, Zhao, Qiang, Windecker, Stephan, Gibson, Charles M, Kim, Byeong-Keuk, Watanabe, Hirotoshi, Song, Young Bin, Zhu, Yunpeng, Vranckx, Pascal, Mehta, Shamir, Hong, Sung-Jin, Ando, Kenji, Gwon, Hyeon-Cheol, Calabrò, Paolo, Serruys, Patrick W, Dangas, George D, McFadden, Eùgene P, Angiolillo, Dominick J, Heg, Dik, Valgimigli, Marco
Format:	Journal Article
Language:	English
Published:	United States 14.02.2023
Subjects:	Aspirin Drug Therapy, Combination Dual Anti-Platelet Therapy Hemorrhage - chemically induced Hemorrhage - epidemiology Humans Percutaneous Coronary Intervention - adverse effects Platelet Aggregation Inhibitors Purinergic P2Y Receptor Antagonists Treatment Outcome meta-analysis percutaneous coronary intervention complex PCI P2Y inhibitors DAPT
ISSN:	1558-3597
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!